Compare GRVY & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GRVY | CYRX |
|---|---|---|
| Founded | 2000 | 1999 |
| Country | South Korea | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 399.1M | 472.7M |
| IPO Year | 2005 | N/A |
| Metric | GRVY | CYRX |
|---|---|---|
| Price | $68.91 | $8.34 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $12.83 |
| AVG Volume (30 Days) | 29.6K | ★ 354.9K |
| Earning Date | 11-07-2025 | 03-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 8.02 | 1.27 |
| Revenue | ★ $399,496,744.00 | $243,795,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $9.12 |
| P/E Ratio | $8.30 | ★ $6.51 |
| Revenue Growth | 12.13 | ★ 41.27 |
| 52 Week Low | $53.12 | $4.58 |
| 52 Week High | $74.75 | $11.45 |
| Indicator | GRVY | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 50.17 | 33.46 |
| Support Level | $68.00 | $8.03 |
| Resistance Level | $70.01 | $8.91 |
| Average True Range (ATR) | 3.80 | 0.47 |
| MACD | -0.70 | -0.16 |
| Stochastic Oscillator | 25.53 | 18.68 |
GRAVITY Co Ltd is an online and mobile games developer and publisher based in Korea. Its principal product, Ragnarok Online, is an online game which is available in more than 91 markets. Its games include Ragnarok Online, Requiem, Dragonica (Dragon Saga), Ragnarok Online II, Requiem Online, and R.O.S.E. Online. The company generates revenue from online games, mobile games and other sources including character based merchandise and animation.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.